Form 8-K · Current report
IQVIA 8-K, filed Sep 23, 2026
- Filed
- CIK
- 0001478242
- Accession no.
- 0001193125-26-399616
Summary
IQVIA Inc., a wholly owned subsidiary of IQVIA Holdings Inc., completed a $2.0 billion offering of 6.375% senior notes due 2034. Net proceeds are intended to redeem IQVIA Inc.'s 5.000% senior notes due 2026, repay part of its revolving credit facility, and pay related fees and expenses.
Key points
- The notes are unsecured, mature on March 15, 2034, and pay interest semi-annually beginning March 15, 2027.
- The notes were issued under an indenture with U.S. Bank Trust Company, National Association as trustee and certain IQVIA Inc. subsidiaries as guarantors.
- IQVIA Inc. may redeem the notes before maturity, initially subject to a make-whole premium and later at a declining premium from 3.188% to 0.000%.
- Net proceeds will redeem in full IQVIA Inc.'s 5.000% senior notes due 2026, repay a portion of its revolving credit facility, and pay offering fees and expenses.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 1.01Entry into a Material Definitive Agreement
- 2.03Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
- 9.01Financial Statements and Exhibits
From the filing
Item 1.01 Entry into a Material Definitive Agreement Notes Offering and Notes Indenture On September 23, 2026, IQVIA Inc. (the “Issuer”), a wholly owned subsidiary of IQVIA Holdings Inc., completed the issuance and sale of $2,000,000,000 in gross proceeds of 6.375% senior notes due 2034 (the “Notes”). The Notes were issued pursuant to an Indenture, dated September 23, 2026 (the “Indenture”), among the Issuer, U.S. Bank Trust Company, National Association, as trustee of the Notes, and certain subsidiaries of the Issuer as guarantors. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.